Product Name

  • Name

    Orotic acid

  • EINECS 200-619-8
  • CAS No. 65-86-1
  • Article Data66
  • CAS DataBase
  • Density 1.642 g/cm3
  • Solubility slightly soluble in water, very slightly soluble in alcohol and organic solvents, insoluble in ether
  • Melting Point 345-346 °C
  • Formula C5H4N2O4
  • Boiling Point 656.9 °C at 760 mmHg
  • Molecular Weight 156.098
  • Flash Point 351.1 °C
  • Transport Information
  • Appearance white crystalline powder
  • Safety 26-36/37/39-22
  • Risk Codes 22-36/37/38
  • Molecular Structure Molecular Structure of 65-86-1 (Orotic acid)
  • Hazard Symbols HarmfulXn,IrritantXi
  • Synonyms Orotic acid(8CI);1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid;2,4-Dihydroxypyrimidine-6-carboxylic acid;2,6-Dihydroxy-4-pyrimidinecarboxylicacid;2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid;6-Carboxyuracil;6-Uracilcarboxylic acid;Animal galactose factor;NSC 79560;NSC 9791;Orodin;Orotonin;Oroturic;Orotyl;Vitamin B13;Whey factor;
  • PSA 103.02000
  • LogP -1.23860

Synthetic route

6-Methyluracil
626-48-2

6-Methyluracil

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With 2,2'-azobis(isobutyronitrile); oxygen; cobalt(II) acetate; acetic acid at 80℃; for 15h;92%
With potassium hydroxide; potassium hexacyanoferrate(III)
2,4-imidazolidinedione
461-72-3

2,4-imidazolidinedione

Glyoxilic acid
298-12-4

Glyoxilic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With sodium hydroxide In water at 115 - 120℃; for 2h; Temperature; Large scale;91.9%
(2Z)-(2,5-dioxoimidazolidin-4-ylidene)acetic acid
153816-00-3

(2Z)-(2,5-dioxoimidazolidin-4-ylidene)acetic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With potassium hydroxide at 64℃; for 3h;85%
With potassium hydroxide at 64℃; for 3h; Mechanism; Kinetics; var. conc. of KOH;85%
C5H6N2O4

C5H6N2O4

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With oxygen; palladium dichloride In N,N-dimethyl-formamide at 80℃; under 760.051 Torr; for 36h; Reagent/catalyst; Solvent; Pressure; Temperature;85%
glycoluril
496-46-8

glycoluril

Glyoxal
131543-46-9

Glyoxal

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
Stage #1: glycoluril; Glyoxal With sodium hydroxide In water for 8h; Autoclave; Reflux; Large scale;
Stage #2: With chlorine at 20℃; Time; Large scale;
33%
orotoaldehyde
36327-91-0

orotoaldehyde

A

6-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione
22126-44-9

6-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione

B

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With potassium hydroxide
orotoaldehyde
36327-91-0

orotoaldehyde

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With sodium dichromate; sulfuric acid
6-oxo-2-thioxo-1,2,3,6-tetrahydro-pyrimidine-4-carbaldehyde
16953-46-1

6-oxo-2-thioxo-1,2,3,6-tetrahydro-pyrimidine-4-carbaldehyde

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With sodium dichromate; sulfuric acid
Multi-step reaction with 2 steps
1: aqueous KOH
2: aqueous alkali .H2O2
View Scheme
2-thioorotic acid
6953-78-2

2-thioorotic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With alkali .H2O2
6-carboxymethyluracil
4628-39-1

6-carboxymethyluracil

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With potassium hydroxide; potassium hexacyanoferrate(III) 22 d;
2-(methylthio)-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid
6314-14-3

2-(methylthio)-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With hydrogenchloride
6-diethoxymethyl-1H-pyrimidine-2,4-dione
16953-48-3

6-diethoxymethyl-1H-pyrimidine-2,4-dione

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With sodium dichromate; sulfuric acid
Multi-step reaction with 2 steps
1: Hydrolysis
2: Na2Cr2O7/H2SO4
View Scheme
6-diethoxymethyl-2-thioxo-2,3-dihydro-1H-pyrimidin-4-one
16953-49-4

6-diethoxymethyl-2-thioxo-2,3-dihydro-1H-pyrimidin-4-one

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With sodium dichromate; sulfuric acid
Multi-step reaction with 3 steps
1: aqueous H2O2; aqueous NaOH
2: Hydrolysis
3: Na2Cr2O7/H2SO4
View Scheme
Multi-step reaction with 2 steps
1: aqueous H2O2; aqueous NaOH
2: Na2Cr2O7/H2SO4
View Scheme
(2,5-dioxo-imidazolidin-4-yliden)-acetic acid
58668-24-9

(2,5-dioxo-imidazolidin-4-yliden)-acetic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With potassium hydroxide
2,6-Dioxo-3,6-dihydro-2H-[1,3]oxazine-4-carboxylic acid
119767-58-7

2,6-Dioxo-3,6-dihydro-2H-[1,3]oxazine-4-carboxylic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With ammonia In various solvent(s)
methyl N1,N3-dibenzyloxymethyl-orotate
80140-18-7

methyl N1,N3-dibenzyloxymethyl-orotate

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With trimethylsilyl iodide; water 1.) chloroform, reflux, 6 h, 2.) reflux, 30 min; 160-180 deg C, 15 min; reflux; Yield given. Multistep reaction;
uracil
66-22-8

uracil

A

orotic acid
65-86-1

orotic acid

B

isoorotidine
489-36-1

isoorotidine

Conditions
ConditionsYield
at 37℃; for 72h; Product distribution; strain 556F from Bacillus subtilis, pH 7.2; effect of different amounts of uracil, other mutants of Bacillus subtilis;
L-dihydroorotic acid
5988-19-2

L-dihydroorotic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With dihydroorotate dehydrogenase; bis(1-chloro-2-propyl) ether; All-Trans Coenzyme Q6; Triton X-100 In water at 37℃; pH=7.8;
With dihydroorotate dehydrogenase In phosphate buffer at 22℃; pH=7; Enzyme kinetics; Further Variations:; also in the presence of detergent;
With human dihydroorotate dehydrogenase; 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone Enzyme kinetics;
With 2,3-Dimethoxy-5-methyl-1,4-benzoquinone; 2,6-Dichlorophenolindophenol; glycerol; sodium chloride; Triton X-100 In water; N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid Microbiological reaction; Enzymatic reaction;
With decylubiquinone; pfDHODH at 25℃; Enzyme kinetics; buffer C;
4.5-dichloro-2.6-dioxo-hexahydropyrimidine-carboxylic acid-(4)

4.5-dichloro-2.6-dioxo-hexahydropyrimidine-carboxylic acid-(4)

orotic acid
65-86-1

orotic acid

(2,5-dioxo-imidazolidin-4-yliden)-acetic acid
58668-24-9

(2,5-dioxo-imidazolidin-4-yliden)-acetic acid

aqueous KOH

aqueous KOH

orotic acid
65-86-1

orotic acid

uracil-carboxylic acid-(4)-amide

uracil-carboxylic acid-(4)-amide

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With potassium hydroxide
uracil-carboxylic acid-(4)-ethyl ester

uracil-carboxylic acid-(4)-ethyl ester

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With potassium hydroxide
dialuryldiazoacetic acid ethyl ester

dialuryldiazoacetic acid ethyl ester

A

orotic acid
65-86-1

orotic acid

B

5-ethoxycarbonylmethylene-hydantoin

5-ethoxycarbonylmethylene-hydantoin

Conditions
ConditionsYield
With sodium hydroxide
ureidosuccinic acid
923-37-5, 173298-46-9

ureidosuccinic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 77 percent / 20percent aq. HCl
2: 71 percent / Br2 / acetic acid / 4 h / 100 °C
3: 85 percent / aq. KOH / 3 h / 64 °C / var. conc. of KOH
View Scheme
5-hydantoinacetic acid
5427-26-9

5-hydantoinacetic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 71 percent / Br2 / acetic acid / 4 h / 100 °C
2: 85 percent / aq. KOH / 3 h / 64 °C / var. conc. of KOH
View Scheme
Multi-step reaction with 2 steps
1: bromine; acetic acid / Beim Erhitzen des Reaktionsprodukts mit H2O
2: aqueous KOH
View Scheme
5-fluoro-1H-indole-2,3-dione
443-69-6

5-fluoro-1H-indole-2,3-dione

5-amino-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
7164-43-4

5-amino-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
1.1 g (73%)
cyanomethylurea
5962-07-2

cyanomethylurea

Glyoxilic acid
298-12-4

Glyoxilic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With sodium hydroxide In methanol; water
With sodium hydroxide for 2h; Reflux; Large scale;
orotidine 5'-monophosphate
2149-82-8

orotidine 5'-monophosphate

A

orotic acid
65-86-1

orotic acid

B

5-phosphoribosyl-1-pyrophosphate
97-55-2, 7540-64-9, 99945-37-6, 130384-52-0

5-phosphoribosyl-1-pyrophosphate

Conditions
ConditionsYield
With Salmonella typhimurium OMP synthase wild type; magnesium chloride at 30℃; pH=8; Kinetics; Reagent/catalyst; aq. phosphate buffer; Enzymatic reaction;
4,5-dihydroorotic acid
155-54-4

4,5-dihydroorotic acid

orotic acid
65-86-1

orotic acid

Conditions
ConditionsYield
With dihydroorotate dehydrogenase Enzymatic reaction;
With dihydroorotate dehydrogenase; coenzyme Q0 pH=8; Enzymatic reaction;
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

orotic acid
65-86-1

orotic acid

2,6-Bis-trimethylsilanyloxy-pyrimidine-4-carboxylic acid
32865-94-4

2,6-Bis-trimethylsilanyloxy-pyrimidine-4-carboxylic acid

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane Ambient temperature;99%
orotic acid
65-86-1

orotic acid

sitagliptin
486460-32-6

sitagliptin

sitagliptin orotate
1246343-77-0

sitagliptin orotate

Conditions
ConditionsYield
In acetonitrile at 25 - 75℃; Product distribution / selectivity;99%
In water at 35 - 37℃; for 0.166667h;
orotic acid
65-86-1

orotic acid

acetyl 2,3-O-isopropylidene-α,β-ribofuranose

acetyl 2,3-O-isopropylidene-α,β-ribofuranose

1'-O-acetyl-2',3'-O-isopropylidene-5'-O-orotyl-D-ribofuranoside

1'-O-acetyl-2',3'-O-isopropylidene-5'-O-orotyl-D-ribofuranoside

Conditions
ConditionsYield
Stage #1: orotic acid With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 20℃; for 16h;
Stage #2: acetyl 2,3-O-isopropylidene-α,β-ribofuranose With pyridine hydrochloride In acetonitrile at 20℃;
98%
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-yl)-N-methylmethanamine

1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-yl)-N-methylmethanamine

orotic acid
65-86-1

orotic acid

1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine orotate

1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine orotate

Conditions
ConditionsYield
In acetone for 0.5h; Solvent; Reflux;98%
4-[ethyl(dimethyl)ammonio]butanoate
1293923-09-7

4-[ethyl(dimethyl)ammonio]butanoate

orotic acid
65-86-1

orotic acid

3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate
1404369-24-9

3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate

Conditions
ConditionsYield
In isopropyl alcohol97.4%
orotic acid
65-86-1

orotic acid

tenofovir disoproxil

tenofovir disoproxil

9-[2-[(R)[[bis[[isopropoxycarbonyl]oxy]methoxy]phosphinyl]methoxy]propyl]adenine orotate

9-[2-[(R)[[bis[[isopropoxycarbonyl]oxy]methoxy]phosphinyl]methoxy]propyl]adenine orotate

Conditions
ConditionsYield
With triethylamine In water; dimethyl sulfoxide at 20 - 30℃; Temperature; Solvent; Reagent/catalyst;97%
In methanol; water at 20 - 70℃; Solvent;85%
orotic acid
65-86-1

orotic acid

L-carnitine
541-15-1

L-carnitine

L-carnitine oroate

L-carnitine oroate

Conditions
ConditionsYield
In water; acetone for 5h; Solvent; Reflux;96%
edoxaban

edoxaban

orotic acid
65-86-1

orotic acid

N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide orotinate

N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide orotinate

Conditions
ConditionsYield
In acetonitrile at 60℃; for 5h;96%
In ethanol at 65℃;5.5 g
orotic acid
65-86-1

orotic acid

1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-6-carbonsaeuremethylester
4116-39-6

1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-6-carbonsaeuremethylester

Conditions
ConditionsYield
In methanol; diethyl ether at 0℃;95%
In methanol Ambient temperature;93%
AMD070
558447-26-0

AMD070

orotic acid
65-86-1

orotic acid

(S)-(N'-(1H-benzimidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl))-1,4-butanediamine orotate
880549-28-0

(S)-(N'-(1H-benzimidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl))-1,4-butanediamine orotate

Conditions
ConditionsYield
In methanol; water at 20℃; for 1h;95%
orotic acid
65-86-1

orotic acid

5-nitroorotic acid
17687-24-0

5-nitroorotic acid

Conditions
ConditionsYield
With sulfuric acid; nitric acid at 15 - 48℃; for 6h; Temperature; Cooling with ice;95%
With sulfuric acid; nitric acid In water at 50 - 55℃; for 3h;90%
Stage #1: orotic acid With sodium hydroxide In water for 3h;
Stage #2: With sulfuric acid; nitric acid In water at 25 - 45℃; Inert atmosphere;
88.6%
With sulfuric acid; nitric acid In water at 50 - 55℃;
orotic acid
65-86-1

orotic acid

5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid
37832-55-6

5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylic acid

Conditions
ConditionsYield
With hydrazine hydrate In water at 90℃; for 5h; Temperature;95%
1-O-benzoyl-2,3-O-isopropylidene-D-ribofuranoside

1-O-benzoyl-2,3-O-isopropylidene-D-ribofuranoside

orotic acid
65-86-1

orotic acid

1'-O-benzoyl-2',3'-O-isopropylidene-5'-O-orotyl-D-ribofuranoside

1'-O-benzoyl-2',3'-O-isopropylidene-5'-O-orotyl-D-ribofuranoside

Conditions
ConditionsYield
Stage #1: orotic acid With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 20℃; for 16h;
Stage #2: 1-O-benzoyl-2,3-O-isopropylidene-D-ribofuranoside With pyridine hydrochloride In acetonitrile at 20℃; for 4h;
94%
methanol
67-56-1

methanol

orotic acid
65-86-1

orotic acid

methyl orotate
6153-44-2

methyl orotate

Conditions
ConditionsYield
With thionyl chloride at 0 - 5℃; for 6h; Reflux;92.9%
With hydrogenchloride for 24h; Fischer esterification; Heating;91%
With hydrogenchloride90%
orotic acid
65-86-1

orotic acid

α-chloroorotic acid
36313-98-1

α-chloroorotic acid

Conditions
ConditionsYield
Stage #1: orotic acid With iron(III) chloride; acetic anhydride; acetic acid at 90 - 95℃;
Stage #2: With sulfuryl dichloride Reagent/catalyst; Temperature; Reflux;
92%
With hydrogenchloride; dihydrogen peroxide
(2S,4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine
252870-53-4

(2S,4E)-N-methyl-5-(5-isopropoxy-3-pyridyl)-4-penten-2-amine

orotic acid
65-86-1

orotic acid

orotic acid salt of (2S)-(4E)-N-methyl-5-[5-isopropoxypyridin-3-yl]-4-penten-2-amine

orotic acid salt of (2S)-(4E)-N-methyl-5-[5-isopropoxypyridin-3-yl]-4-penten-2-amine

Conditions
ConditionsYield
In ethanol Heating / reflux;91.4%
1-O-pivaloyl-2,3-O-isopropylidene-D-ribofuranoside

1-O-pivaloyl-2,3-O-isopropylidene-D-ribofuranoside

orotic acid
65-86-1

orotic acid

1'-O-pivaloyl-2',3'-O-isopropylidene-5'-O-orotyl-D-ribofuranoside

1'-O-pivaloyl-2',3'-O-isopropylidene-5'-O-orotyl-D-ribofuranoside

Conditions
ConditionsYield
Stage #1: orotic acid With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 20℃; for 16h;
Stage #2: 1-O-pivaloyl-2,3-O-isopropylidene-D-ribofuranoside With pyridine hydrochloride In acetonitrile at 20℃;
90%
N-hydroxy-2-(4-(4-phenylbutyl)phenyl)acetamide
342373-13-1

N-hydroxy-2-(4-(4-phenylbutyl)phenyl)acetamide

orotic acid
65-86-1

orotic acid

N-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyloxy)-2-(4-(4-phenylbutyl)phenyl)acetamide

N-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyloxy)-2-(4-(4-phenylbutyl)phenyl)acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃;90%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide90%
orotic acid
65-86-1

orotic acid

bis(tri-n-butyltin)oxide
56-35-9

bis(tri-n-butyltin)oxide

C34H62N4O9Sn2

C34H62N4O9Sn2

Conditions
ConditionsYield
In toluene for 6h; Reflux; Inert atmosphere; Dean-Stark;90%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

bis(2,2'-bipyridine)dichlororuthenium(II) dihydrate

bis(2,2'-bipyridine)dichlororuthenium(II) dihydrate

orotic acid
65-86-1

orotic acid

bis(2,2’-bipyridine) orotate ruthenium(II)

bis(2,2’-bipyridine) orotate ruthenium(II)

Conditions
ConditionsYield
Stage #1: bis(2,2'-bipyridine)dichlororuthenium(II) dihydrate; orotic acid In ethanol at 125℃; for 2h; Sealed tube; Microwave irradiation;
Stage #2: ammonium hexafluorophosphate In ethanol; water at 20℃;
89%
orotic acid
65-86-1

orotic acid

ethyl iodide
75-03-6

ethyl iodide

ethyl orotate
1747-53-1

ethyl orotate

Conditions
ConditionsYield
Stage #1: orotic acid With 1,8-diazabicyclo[5.4.0]undec-7-ene In water; N,N-dimethyl-formamide for 0.0833333h;
Stage #2: ethyl iodide In water; N,N-dimethyl-formamide at 60℃; for 5h;
88%
Stage #1: orotic acid With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide for 0.0833333h;
Stage #2: ethyl iodide In N,N-dimethyl-formamide at 60℃; for 5h;
88%
10-ethoxy-6-(methoxymethyl)-8-(morpholinomethyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-5(6H)-one

10-ethoxy-6-(methoxymethyl)-8-(morpholinomethyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-5(6H)-one

orotic acid
65-86-1

orotic acid

10-ethoxy-8-(morpholinomethyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-5(6H)-one 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid

10-ethoxy-8-(morpholinomethyl)-1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-5(6H)-one 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid

Conditions
ConditionsYield
In ethanol at 90℃; for 3h;88%
orotic acid
65-86-1

orotic acid

glycine tert-butyl ester hydrochloride
27532-96-3

glycine tert-butyl ester hydrochloride

Ort-Gly-O-t-Bu

Ort-Gly-O-t-Bu

Conditions
ConditionsYield
With 4-methyl-morpholine; N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline In N,N-dimethyl-formamide at 50 - 55℃;87%
orotic acid
65-86-1

orotic acid

1',5'-O-diorotyl-2',3'-O-isopropylidene-D-ribofuranoside

1',5'-O-diorotyl-2',3'-O-isopropylidene-D-ribofuranoside

Conditions
ConditionsYield
With pyridine hydrochloride; 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 20℃;87%
orotic acid
65-86-1

orotic acid

O-desmethylvenlafaxine
93413-62-8

O-desmethylvenlafaxine

O-desmethyl-venlafaxine orotate
1174652-08-4

O-desmethyl-venlafaxine orotate

Conditions
ConditionsYield
In diethyl ether; ethanol at 0 - 20℃; Reflux;85.4%
orotic acid
65-86-1

orotic acid

((S)-2-amino-4-methylpentanoyl)-L-leucine methyl ester hydrochloride
6491-83-4, 63889-48-5, 66190-38-3

((S)-2-amino-4-methylpentanoyl)-L-leucine methyl ester hydrochloride

orotyl-L-leucyl-L-leucine methyl ester
74019-79-7

orotyl-L-leucyl-L-leucine methyl ester

Conditions
ConditionsYield
With 4-methyl-morpholine; N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline In N,N-dimethyl-formamide at 50 - 55℃;85%
furan-2-ylmethanamine
617-89-0

furan-2-ylmethanamine

orotic acid
65-86-1

orotic acid

N-(furan-2-ylmethyl)-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxamide
302603-04-9

N-(furan-2-ylmethyl)-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxamide

Conditions
ConditionsYield
for 0.166667h; microwave irradiation;85%

Orotic acid Consensus Reports

Reported in EPA TSCA Inventory.

Orotic acid Specification

The Orotic acid, with the CAS registry number 65-86-1, is also known as 1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidecarboxylic acid. It belongs to the product category of Vitamin Ingredients. Its EINECS number is 200-619-8. This chemical's molecular formula is C5H4N2O4 and molecular weight is 156.10. What's more, its systematic name is 2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid. Its classification codes are: (1)Drug / Therapeutic Agent; (2)Mutation data. This chemical should be sealed and stored in a cool and dry place. Moreover, it should be protected from moisture and mildew. It is a heterocyclic compound and an acid. Historically it was believed to be part of the Vitamin B complex and was called vitamin B13, but it is now known that it is not a vitamin. The compound is manufactured in the body by intestinal flora. It is sometimes used as a mineral carrier in some dietary supplements (to increase their bioavailability), most commonly for lithium orotate. This chemical is used in biochemical research, especially the biosynthesis of nucleic acids.

Physical properties of Orotic acid are: (1)ACD/LogP: -0.84; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -3.64; (4)ACD/LogD (pH 7.4): -4.56; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 6; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 1; (12)Polar Surface Area: 95.5 Å2; (13)Index of Refraction: 1.568; (14)Molar Refractivity: 31.111 cm3; (15)Molar Volume: 95.051 cm3; (16)Polarizability: 12.333×10-24cm3; (17)Surface Tension: 68.58 dyne/cm; (18)Density: 1.642 g/cm3; (19)Flash Point: 351.1 °C; (20)Enthalpy of Vaporization: 101.63 kJ/mol; (21)Boiling Point: 656.9 °C at 760 mmHg; (22)Vapour Pressure: 3.76E-18 mmHg at 25°C.

Preparation: this chemical can be prepared by (2,5-dioxo-imidazolidin-4-ylidene)-acetic acid at the temperature of 64 °C. This reaction will need reagent 1 M aq. KOH with the reaction time of 3 hours. The yield is about 85%.

Orotic acid can be prepared by (2,5-dioxo-imidazolidin-4-ylidene)-acetic acid at the temperature of 64 °C

Uses of Orotic acid: it can be used to produce orotic acid N-hydroxysuccinimide ester at the ambient temperature. It will need reagent dicyclohexylcarbodiimide and solvent dimethylsulfoxide. The yield is about 76%.

Orotic acid can be used to produce orotic acid N-hydroxysuccinimide ester at the ambient temperature

When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to eyes, respiratory system and skin. It is harmful if swallowed. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. You should not breathe dust. When using it, you need to wear suitable protective clothing, gloves and eye/face protection.

You can still convert the following datas into molecular structure:
(1)SMILES: O=C(O)\C1=C\C(=O)NC(=O)N1
(2)Std. InChI: InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)
(3)Std. InChIKey: PXQPEWDEAKTCGB-UHFFFAOYSA-N

The toxicity data is as follows:  

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 841mg/kg (841mg/kg)   Drugs in Japan Vol. 6, Pg. 165, 1982.
mouse LD50 intravenous 770mg/kg (770mg/kg)   Drugs in Japan Vol. 6, Pg. 165, 1982.
mouse LD50 oral 2gm/kg (2000mg/kg)   Drugs in Japan Vol. 6, Pg. 165, 1982.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View